Fact Check: Ivermectin NOT ‘Vindicated (AGAIN)’ In Peer-Reviewed Study Showing 92% Reduction In COVID-19 Mortality
Was ivermectin “vindicated (again)” in a peer-reviewed study that showed a 92% reduction in COVID-19 mortality? No, that’s not true: The claims about ivermectin were published on an “open science” site where scientists may share findings before they have been vetted by independent experts. The U.S. Food and Drug Administration (FDA) has not authorized the use of the anti-parasite drug for the treatment of COVID-19.
The claim appeared in a Facebook post (archived here) on September 5, 2022, under the title “ᴅᴇᴇᴘ sᴛᴀᴛᴇ ғᴀɪʟᴜʀᴇs ᴋᴇᴇᴘ ᴘᴜsʜɪɴɢ ʙᴀᴅ ᴄʜᴏɪᴄᴇs. It opened:
Ivermectin Vindicated (AGAIN) in Peer-Reviewed Study Showing 92% Reduction in COVID-19 Mortality, Marjorie Taylor Greene Demands Accountability
This is what the post looked like on Facebook at the time of writing:
(Source: Facebook screenshot taken on Tue Sep 6 16:50:09 2022 UTC)
The claim about ivermectin appears a little more than halfway (29:58) through an “On The Fringe” podcast hosted by “Dan Radiostyle.” The host talks about a September 3, 2022, article published (archived here) on the En Volve website called “Ivermectin Vindicated (AGAIN) in Peer-Reviewed Study Showing 92% Reduction in COVID-19 Mortality, Marjorie Taylor Greene Demands Accountability.”
The article cites an August 31, 2022, study on the drug that appears on the Cureus website, which bills itself as an “Open Access medical journal for a new generation of doctors, researchers and patients. We’re eliminating barriers to the generation and dissemination of medical knowledge.”
“This is not a well-constructed study,” said Dr. James Lawler with the Division of Infectious Diseases at the University of Nebraska Medical Center in a September 6, 2022, email to Lead Stories. “I think the first warning should be that it is published on an online portal that really isn’t a traditional peer-reviewed scientific journal.”
In his email to Lead Stories, Lawler said he has several concerns about the study:
Several RCTs [randomized controlled trials] and legitimate meta-analyses by universally respected scientific groups like Cochrane Database have been done for ivermectin and the results are pretty clear – it provides no benefit in COVID-19.
Lead Stories has written about one the study’s authors before. Pierre Kory is a physician affiliated with the Front Line COVID-19 Critical Care Alliance (FLCCC), an anti-vaccine group that has been cited for perpetuating unsubstantiated claims regarding the virus in a scholarly article in Frontiers in Pharmacology. Kory is a founding member of FLCCC.
Asked for a response to the study’s claims, FDA Press Officer Chanapa Tantibanchachai told Lead Stories in a September 6, 2022, email that the agency does not comment on third-party research:
Currently, FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans. To date, published clinical trials have shown mixed results. Additional clinical trials assessing ivermectin tablets for the prevention or treatment of COVID-19 are ongoing. Information on clinical trials of ivermectin in COVID-19 can be accessed at https://www.clinicaltrials.gov/.
While FDA-approved products may be prescribed by physicians for unapproved uses if they determine it is appropriate for treating their patients, including during COVID-19, the safety and efficacy of ivermectin for the prevention or treatment of COVID-19 has not been established. Taking ivermectin can interact with other medications the patient is taking and cause side effects such as nausea, vomiting, diarrhea, hypotension (low blood pressure), allergic reactions (itching and hives), dizziness and ataxia (problems with balance).
The FDA offers a fact sheet discouraging the use of ivermectin against COVID-19: Why You Should Not Use Ivermectin to Treat or Prevent COVID-19.
In another September 6, 2022, email to Lead Stories, the Centers for Disease Control and Prevention echoed the FDA, saying the anti-parasitic is not authorized to prevent or treat COVID-19 in humans:
The National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel has determined that there are currently insufficient data to recommend using ivermectin to treat COVID-19. Clinicians and public health practitioners should educate patients about the risks of using ivermectin without an indication or prescription, as well as about the risks of ingesting ivermectin products that are meant solely for external use or veterinary use. COVID-19 vaccination is safe and the most effective means to prevent infection and protect against severe disease and death from SARS-CoV-2, the virus that causes COVID-19. Clinicians are strongly encouraged to educate patients to use proven COVID-19 prevention measures, especially getting vaccinated and boosted as soon as eligible, and use FDA-authorized treatment.
Lead Stories has written dozens of stories debunking false claims about ivermectin as a possible treatment for COVID.
This article has been archived for your research. The original version from Lead Stories can be found here.
